Method for identifying behaviour change techniques (BCTs) for stop smoking behavioural support delivered in practice
|
Author(s)
Fabiana Lorencatto, Susan Michie and Robert West
|
| Presenter(s) |
Fabiana Lorencatto Research Associate/ PhD Student, NCSCT |
Abstract Background: Behavioural support effectively helps smokers quit. However, it is often unclear which BCTs comprise behavioural support interventions, or which contribute to quit outcomes. A taxonomy-based method for identifying BCTs included in SSSs treatment protocols has recently been developed (Michie et al. 2011). The extent to which this may be used to reliably identify and describe BCTs delivered in practice remains to be ascertained.
Methods: Fourteen behavioural support sessions delivered by the SSSs were audio-recorded. Sessions were transcribed and analysed using content analysis. Three independent researchers coded transcripts using a taxonomy of 40 smoking cessation BCTs to identify and categorize BCTs delivered in each session. The frequency of BCTs included in sessions was recorded and inter-rater agreement assessed.
Findings: 37 BCTs (92.5%) from the taxonomy were used at least once across sessions. An average of 20 BCTs were identified per session (SD 2.79; Range:12-31). Average inter-rater coding reliability was high (94.7% agreement).
Discussion: It is possible to use taxonomy-based methods to reliably identify and classify BCTs delivered in practice. This holds implications for research, service monitoring, practitioner training and continuing professional development. The next step is to establish the generalisability of this and the association between BCTs delivered in practice with quit outcomes.
|
Source of funding: NHS Centre for Smoking Cessation And Training
|
Declaration of interest: Fabiana Lorancatto has received travel funds and hospitality from Pfizer, who manufacture Champix.
Susan Michie has received travel funds and hospitality from Pfizer, who manufacture Champix. She has received fees for speaking at educational events sponsored by Pfizer. She has received research
funds and consultancy payments from the Department of Health and the Department of Transport.
Robert West has received travel funds and hospitality from, and undertaken research and consultancy for pharmaceutical companies that manufacture or research products aimed at helping smokers to stop. These products include nicotine replacement therapies, Champix and Zyban. This has led to payments to him personally and to his institution. He undertakes lectures and training in smoking cessation methods which have led to payments to him personally and to his institution. He also receives royalties from books on smoking cessation. He has received research grants from medical charities and government departments.
|
| |
